Status:
WITHDRAWN
Conversion Surgery in Stage IV or Unresectable Gastric Cancer
Lead Sponsor:
Cho Hyun Park
Collaborating Sponsors:
The Catholic University of Korea
Peking University
Conditions:
Stage IV or Unresectable Gastric Cancer
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
This study aims to identify the safety and the survival benefit of the conversion surgery in stage IV or unresectable gastric cancer. The study designed single-arm phase II trial. All the patients wou...
Detailed Description
The survival rate of patients with stage IV gastric cancer (GC) is very low. Recently, several retrospective studies about conversion surgery have been introduced. The results of the studies showed ar...
Eligibility Criteria
Inclusion
- Gastric adenocarcinoma
- Stage IV or unresectable gastric cancer was diagnosed by pre-operative evaluation including endoscopy, endoscopic ultrasound, Computed tomography (CT), Positron emission tomography-computed tomography (PET CT), or staging laparoscopy
- Partial or complete response to chemotherapy
- Eastern Cooperative Oncology Group (ECOG) score \<3
- Who agreed to enroll the study
Exclusion
- Synchronous or metachronous malignancy
- remnant gastric cancer
- BMI less than 18.5
- Pregnancy
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03366961
Start Date
December 1 2017
End Date
December 31 2022
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul St. Mary's Hospital
Seoul, South Korea, 06523